Literature DB >> 2494297

Psychoneuroendocrine research in depression. II. Hormonal responses to releasing hormones as a probe for hypothalamic-pituitary-endorgan dysfunction.

K P Lesch1, R Rupprecht.   

Abstract

The rapid growth of fundamental research in neuroendocrinology includes advances in our understanding of the role of neurotransmitters in the control of hypophysiotropic neurons, the concept of neurosecretion, the portal circulation chemotransmitter hypothesis of anterior pituitary regulation, and the chemical structures of the hypophysiotropic hormones. These advances correspond to the emergence of psychoneurobiology, with the appreciation of the roles of neuropeptides, such as hypothalamic releasing and inhibiting hormones, their relevance to brain function and possible involvement in psychiatric disease, and their introduction into psychoneuroendocrinological studies. The subject of the present review is to summarize and integrate current knowledge of the neuroendocrinology of hypothalamic releasing and inhibiting hormones, to apply it to the understanding of the pathogenesis of depression, and to evaluate their relevance as psychoneuroendocrine research tools.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494297     DOI: 10.1007/bf01258629

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  70 in total

1.  Triiodothyronine, thyroxine, and TSH response to dexamethasone in depressed patients and normal controls.

Authors:  R Rupprecht; C Rupprecht; M Rupprecht; M Noder; J Mahlstedt
Journal:  Biol Psychiatry       Date:  1989-01       Impact factor: 13.382

2.  Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men.

Authors:  S M Rosenthal; J A Hulse; S L Kaplan; M M Grumbach
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

3.  Stimulation and inhibition of corticotrophin releasing factor secretion by beta endorphin.

Authors:  J C Buckingham
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

4.  Somatostatin and GHRH: mood and behavioral regulation.

Authors:  D R Rubinow; R M Post; C L Davis; A R Doran
Journal:  Adv Biochem Psychopharmacol       Date:  1987

5.  The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide.

Authors:  J Boler; F Enzmann; K Folkers; C Y Bowers; A V Schally
Journal:  Biochem Biophys Res Commun       Date:  1969-11-06       Impact factor: 3.575

6.  Human corticotropin-releasing hormone in depression--correlation with thyrotropin secretion following thyrotropin-releasing hormone.

Authors:  F Holsboer; A Gerken; U von Bardeleben; W Grimm; H Beyer; O A Müller; G K Stalla
Journal:  Biol Psychiatry       Date:  1986-06       Impact factor: 13.382

7.  Involvement of hypothalamic somatostatin in the suppression of growth hormone secretion by central corticotropin-releasing factor in conscious male rats.

Authors:  H Katakami; A Arimura; L A Frohman
Journal:  Neuroendocrinology       Date:  1985-11       Impact factor: 4.914

8.  Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly.

Authors:  R Guillemin; P Brazeau; P Böhlen; F Esch; N Ling; W B Wehrenberg
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

9.  Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.

Authors:  D S Charney; G R Heninger; D E Sternberg; K M Hafstad; S Giddings; D H Landis
Journal:  Arch Gen Psychiatry       Date:  1982-03

10.  Diurnal hypersecretion of growth hormone in depression.

Authors:  J Mendlewicz; P Linkowski; M Kerkhofs; D Desmedt; J Golstein; G Copinschi; E Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

View more
  6 in total

Review 1.  The neuroendocrine approach to psychiatric disorders: a critical appraisal.

Authors:  E E Müller
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 2.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

Review 3.  Psychoneuroendocrine research in depression. I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test.

Authors:  R Rupprecht; K P Lesch
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  The effect of medial forebrain bundle lesion on thyrotropin secretion in the rat.

Authors:  A Jaffer; W M Daniels; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

5.  Alpha 2- and beta-adrenergic stimulation of corticosterone secretion in rats.

Authors:  W M Daniels; A Jaffer; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1993-02       Impact factor: 3.996

6.  Effects of alpha 2- and beta-adrenoceptor agonists on growth hormone secretion following lesion of the noradrenergic system of the rat.

Authors:  A Jaffer; W M Daniels; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.